Connect with us

/home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153
">
Warning: Undefined array key 0 in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153

Warning: Attempt to read property "cat_name" on null in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153

Fedora 30 Now Generally Available

Published

on

Reading Time: 5 minutes

Latest version of the Fedora operating systems showcases the future
of Linux, from workstations beyond containerization to cloud-native
servers

RALEIGH, N.C.–(BUSINESS WIRE)–The Fedora Project, a Red Hat, Inc. sponsored and community-driven open
source collaboration, today announced the general availability of Fedora
30, the latest version of the fully open source Fedora operating system.
As with previous iterations of Fedora, Fedora 30 continues the Fedora
Project’s commitment to delivering distinct editions that address
specific computing needs. The Fedora Project community continues to
refine the look and feel of these editions, and Fedora 30 provides a
look at the future of Fedora and the Linux operating system in an IT
landscape powered by Linux containers, Kubernetes and cloud computing.

Fedora 30 brings enhancements to all editions with updates to the common
underlying packages, from bug fixes and performance tweaks to new
versions. In Fedora 30, base updates include Bash shell 5.0, Fish 3.0,
the GNU Compiler Collection (GCC) 9 and Ruby 2.6. Fedora 30 also now
uses the zchunk format for data compression within the DNF repository.
When metadata is compressed using zchunk DNF downloads the differences
between earlier copies of metadata and the current versions, saving on
resources and increasing efficiency.

A fresh look at Fedora editions

In the build-up to Fedora 30, the Fedora Project community took a fresh
look at the computing use cases answered by the three primary editions
of the Fedora operating system: Fedora Workstation, Fedora Server and
Fedora Atomic Host. As the associated technology areas continue to
evolve, these editions have been updated to better reflect the emerging
realities of modern computing:

  • Fedora Workstation continues to be refined and will now also provide a
    container-driven variant in Fedora Silverblue
  • Fedora Atomic Host will now be superseded by Fedora CoreOS as a
    container-centric operating system
  • Fedora Server has been merged with the capabilities of Fedora Cloud
    to provide a more modern take on server operating systems

Fedora 30 Workstation

To help provide developers and desktop users alike with some of the
latest open source advancements, Fedora 30 Workstation includes the
latest version of the GNOME desktop, GNOME 3.32. The desktop includes
fractional scaling, a refreshed visual style, animation improvements and
new icons. Fedora 30 Workstation will also introduce Fedora
Silverblue
, an Atomic Workstation designed to provide an immutable
desktop operating system.

Silverblue brings the capabilities of Fedora CoreOS to the desktop,
creating a workstation environment that can operate hand-in-hand with
Kubernetes. Contributing to the evolution of Silverblue is the Fedora
Project’s continued work on Flatpak, a container-like technology for
building and distributing desktop applications, and part of the
Silverblue mission is to deliver desktop applications for the variant
via Flatpak.

Fedora CoreOS

As Linux containers and Kubernetes take a greater role in IT
infrastructure, the Fedora Project is working to deliver an operating
system tailored for these scenarios. Fedora CoreOS blends many of the
innovative features of CoreOS Container Linux with Project Atomic, and
intends to deliver an operating system based on rpm-ostree and
system-wide immutability. An initial release of Fedora CoreOS is
expected around June 2019.

Fedora 30 Cloud

The use cases for server operating systems are also changing in the face
of containerized applications and hybrid cloud deployments. With this in
mind, the Fedora Project has melded the traditional server capabilities
of Fedora Server with Fedora Cloud, providing a Fedora 30 edition that
can address more varied infrastructure needs.

Beyond the cloud with the Internet-of-Things

In an increasingly interconnected world, the Fedora Project is also
working to address use cases around the Internet-of-Things (IoT) with
Fedora IoT. From home-based projects to industrial R&D testbeds, the
upcoming Fedora IoT edition is intended to provide a foundation for the
next generation of the connected world.

To see Fedora IoT in action and to learn more about Fedora 30 and
Fedora’s extended projects, visit the Fedora booth in the Community
Central area at Red
Hat Summit 2019
on May 6 – 9 in Boston to see Fedora IoT in action.

Supporting Quotes

Matthew Miller, Fedora Project Leader
“Computing scenarios
don’t remain static and neither does Fedora. With the updates around
Fedora 30, we’re providing an evolving spectrum of operating system
editions to better meet diverse IT challenges. From containerized
developer workspaces with Flatpak and Silverblue to expanded server and
container infrastructure options in Fedora 30 Cloud and Fedora CoreOS,
the Fedora Project remains focused on Linux innovation.”

Additional Resources

Connect with Red Hat

About Red Hat, Inc.

Red
Hat
is the world’s leading provider of enterprise open source
software solutions, using a community-powered approach to deliver
reliable and high-performing Linux, hybrid cloud, container, and
Kubernetes technologies. Red Hat helps customers integrate new and
existing IT applications, develop cloud-native applications, standardize
on our industry-leading operating system, and automate, secure, and
manage complex environments. Award-winning
support, training, and consulting services make Red Hat a trusted
adviser to the Fortune 500
. As a strategic partner to cloud
providers, system integrators, application vendors, customers, and open
source communities, Red Hat can help organizations prepare for the
digital future.

Forward-Looking Statements

Certain statements contained in this press release may constitute
“forward-looking statements” within the meaning of the Private
Securities Litigation Reform Act of 1995. Forward-looking statements
provide current expectations of future events based on certain
assumptions and include any statement that does not directly relate to
any historical or current fact. Actual results may differ materially
from those indicated by such forward-looking statements as a result of
various important factors, including: risks related to our pending
merger with International Business Machines Corporation, the ability of
the Company to compete effectively; the ability to deliver and stimulate
demand for new products and technological innovations on a timely basis;
delays or reductions in information technology spending; the integration
of acquisitions and the ability to market successfully acquired
technologies and products; risks related to errors or defects in our
offerings and third-party products upon which our offerings depend;
risks related to the security of our offerings and other data security
vulnerabilities; fluctuations in exchange rates; changes in and a
dependence on key personnel; the effects of industry consolidation;
uncertainty and adverse results in litigation and related settlements;
the inability to adequately protect Company intellectual property and
the potential for infringement or breach of license claims of or
relating to third party intellectual property; the ability to meet
financial and operational challenges encountered in our international
operations; and ineffective management of, and control over, the
Company’s growth and international operations, as well as other factors
contained in our most recent Annual Report on Form 10-K (copies of which
may be accessed through the Securities and Exchange Commission’s website
at www.sec.gov),
including those found therein under the captions “Risk Factors” and
“Management’s Discussion and Analysis of Financial Condition and Results
of Operations”. In addition to these factors, actual future performance,
outcomes, and results may differ materially because of more general
factors including (without limitation) general industry and market
conditions and growth rates, economic and political conditions,
governmental and public policy changes and the impact of natural
disasters such as earthquakes and floods. The forward-looking statements
included in this press release represent the Company’s views as of the
date of this press release and these views could change. However, while
the Company may elect to update these forward-looking statements at some
point in the future, the Company specifically disclaims any obligation
to do so. These forward-looking statements should not be relied upon as
representing the Company’s views as of any date subsequent to the date
of this press release.

Red Hat and the Shadowman logo are trademarks or registered
trademarks of Red Hat, Inc. or its subsidiaries in the U.S. and other
countries. Linux® is the registered trademark of Linus Torvalds in the
U.S. and other countries.

Contacts

John Terrill
Red Hat, Inc.
+1-571-421-8132
[email protected]


Warning: Undefined array key 0 in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 493

Warning: Attempt to read property "cat_ID" on null in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 493

Cannabis

Sannabis, Inc. (OTC: USPS) Unveils Innovative NO LICK! Terpene Spray for Cannabis Products to Enhance CBD and THC to Achieve the Entourage Effect

Published

on

Continue Reading

Cannabis

Cannabis Concentrate Market to Cross US$2.4 Billion by 2030 amid Rising Medical and Recreational Demand

Published

on

Continue Reading

transfer

IMC to transfer its Oranim Pharmacy shares back to the seller

Published

on

imc-to-transfer-its-oranim-pharmacy-shares-back-to-the-seller

TORONTO and GLIL YAM, Israel, April 16, 2024 /PRNewswire/ — IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the “Company” or “IMC“), a leading medical cannabis company with operations in Israel and Germany, is announcing that, further to the news release dated January 12, 2024, the Company has decided not to make remaining installment payments installments (i.e. NIS 5,873K including interest or 2,154K CAD) by IMC Holdings Ltd., and as such will transfer the 51% shares held by IMC Holdings Ltd back to the  seller.

“With the April 1st cannabis legalization in Germany, we are focusing our resources on the German market, where we expect to see the biggest growth potential,” said Oren Shuster, CEO of IMC. “With both of our core markets, Germany and Israel, currently undergoing rapid evolution, we need to assure that we allocate our resources to the growth opportunities where we expect the best return on investment.”

About IM Cannabis Corp.

IMC (Nasdaq: IMCC) (CSE: IMCC) is an international cannabis company that provides premium cannabis products to medical patients in Israel and Germany, two of the largest medical cannabis markets. The Company has recently exited operations in Canada to pivot its focus and resources to achieve sustainable and profitable growth in its highest value markets, Israel and Germany. The Company leverages a transnational ecosystem powered by a unique data-driven approach and a globally sourced product supply chain. With an unwavering commitment to responsible growth and compliance with the strictest regulatory environments, the Company strives to amplify its commercial and brand power to become a global high-quality cannabis player.

The IMC ecosystem operates in Israel through its commercial relationship with Focus Medical Herbs Ltd., which imports and distributes cannabis to medical patients, leveraging years of proprietary data and patient insights. The Company also operates medical cannabis retail pharmacies, online platforms, distribution centers, and logistical hubs in Israel that enable the safe delivery and quality control of IMC’s products throughout the entire value chain. In Germany, the IMC ecosystem operates through Adjupharm GmbH, where it distributes cannabis to pharmacies for medical cannabis patients. Until recently, the Company also actively operated in Canada through Trichome Financial Corp and its wholly owned subsidiaries, where it cultivated, processed, packaged, and sold premium and ultra-premium cannabis at its own facilities under the WAGNERS and Highland Grow brands for the adult-use market in Canada. The Company has exited operations in Canada and considers these operations discontinued.

Disclaimer for Forward-Looking Statements

This press release contains forward-looking information or forward-looking statements under applicable Canadian and U.S. securities laws (collectively, “forward-looking statements”). All information that addresses activities or developments that we expect to occur in the future are forward-looking statements. Forward-looking statements are often, but not always, identified by the use of words such as “seek”, “anticipate”, “believe”, “plan”, “estimate”, “expect”, “likely” and “intend” and statements that an event or result “may”, “will”, “should”, “could” or “might” occur or be achieved and other similar expressions. Forward-looking statements are based on the estimates and opinions of management on the date the statements are made. In the press release, such forward-looking statements include, but are not limited to,  the occurrence of growth opportunities and the likelihood of growth potential.

Forward-looking statements are based on assumptions that may prove to be incorrect, including but not limited to: the development and introduction of new products; continuing demand for medical and adult-use recreational cannabis in the markets in which the Company operates; the Company’s ability to reach patients through both e-commerce and brick and mortar retail operations; the Company’s ability to maintain and renew or obtain required licenses; the effectiveness of its products for medical cannabis patients and recreational consumers; and the Company’s ability to market its brands and services successfully to its anticipated customers and medical cannabis patients.

The above lists of forward-looking statements and assumptions are not exhaustive. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. Actual results may differ materially from those currently anticipated or implied by such forward looking statements due to a number of factors and risks. These include: any failure of the Company to maintain “de facto” control over Focus Medical in accordance with IFRS 10; the failure of the Company to comply with applicable regulatory requirements in a highly regulated industry; unexpected changes in governmental policies and regulations in the jurisdictions in which the Company operates; the effect of the reform on the Company; the Company’s ability to continue to meet the listing requirements of the Canadian Securities Exchange and the NASDAQ Capital Market; any unexpected failure to maintain in good standing or renew its licenses; the ability of the Company and Focus Medical (collectively, the “Group”) to deliver on their sales commitments or growth objectives; the reliance of the Group on third-party supply agreements to provide sufficient quantities of medical cannabis to fulfil the Group’s obligations; the Group’s possible exposure to liability, the perceived level of risk related thereto, and the anticipated results of any litigation or other similar disputes or legal proceedings involving the Group; the impact of increasing competition; any lack of merger and acquisition opportunities; adverse market conditions; the inherent uncertainty of production quantities, qualities and cost estimates and the potential for unexpected costs and expenses; risks of product liability and other safety-related liability from the usage of the Group’s cannabis products; supply chain constraints; reliance on key personnel; the risk of defaulting on existing debt and war, conflict and civil unrest in Eastern Europe and the Middle East

Any forward-looking statement included in this press release is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward-looking information is made.

The Company does not undertake any obligation to update forward-looking statements except as required by applicable securities laws. Investors should not place undue reliance on forward-looking statements. Forward-looking statements contained in this press release are expressly qualified by this cautionary statement.

Company Contacts:

Anna Taranko, Director Investor & Public Relations
IM Cannabis Corp.
+49 157 80554338
[email protected]

Oren Shuster, Chief Executive Officer
IM Cannabis Corp.
[email protected]

Logo – https://mma.prnewswire.com/media/1742228/IM_Cannabis_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/imc-to-transfer-its-oranim-pharmacy-shares-back-to-the-seller-302117984.html

Continue Reading

Trending on Grassnews

GrassNews.net: Your premier portal for the latest developments in the cannabis industry. We provide timely news, insightful analysis, and in-depth features on everything from legislation changes and business trends, to scientific research and lifestyle topics. Stay informed and navigate the rapidly evolving cannabis landscape with GrassNews.net..

Contact us: [email protected]

Editorial / PR Submissions

Copyright © 2007 - 2024 Hipther Agency. Registered in Romania under Proshirt SRL, Company number: 2134306, EU VAT ID: RO21343605. Office address: Blvd. 1 Decembrie 1918 nr.5, Targu Mures, Romania